• Follow the Money: Clinical Effectiveness Studies in Urinary Incontinence, Sickle Cell Disease, Mental Health

    Mar 31, 2022, 01:00 by User Not Found
    Clinical Research News | Funding of clinical effectiveness studies related to urinary incontinence, sickle cell disease, mental health, and hypertension management, a new gene therapy for atrial fibrillation, and funding for cloud-based clinical data analytics.
    Full story
  • Orphan Drug Designation for ALS Treatment, Virtual Assistants in Genetic Counseling, Clinical Research Expansion in Asia

    Mar 30, 2022, 01:00 by User Not Found
    Clinical Research News | New orphan drug designation for ALS treatment, virtual assistants in genetic counseling, AI in healthcare professional engagement, AI-powered pathology for clinical diagnostics, clinical research expansion in Asia, more.
    Full story
  • The Case For Tokenizing Data On Clinical Trial Participants

    Mar 29, 2022, 01:00 by User Not Found
    Clinical Research News | Based on a lively panel discussion at the recent Summit for Clinical Ops Executives (SCOPE), it appears enthusiasm is building for the “tokenization” of clinical research participants to link information from trials to real-world data (RWD) on the same patients. The rationale includes the ability to track individuals more easily over the long haul and contextualize adverse events detected in studies, says Tim Riely, vice president of clinical data analytics at IQVIA.
    Full story
  • Decentralized Clinical Trials: A Revolution Improving Safety, Efficacy, and Speed

    Mar 25, 2022, 01:00 by User Not Found
    Clinical Research News | Decentralized clinical trials (DCTs) are an exciting and fast-growing market showing no signs of slowing down. However, the shift to DCTs can present new challenges. Examples of this include ensuring patient safety throughout clinical trials and safeguarding the quality of data produced by patients.
    Full story
  • Consensus Definition Of ‘Treatment-Resistant Depression’ For Regulatory Trials

    Mar 23, 2022, 15:53 by User Not Found
    Clinical Research News | Hundreds of clinical trials are underway testing therapies for treatment-resistant depression (TRD), yet until very recently there was not a clear definition of what is even being treated. But with newly proposed criteria to describe the condition, researchers and regulatory agencies have a basis for agreement that could help inform study design and potentially improve the lives of millions of people worldwide.
    Full story
  • Addressing the Importance of Biospecimen Collection Protocols and Quality Control Processes for Downstream Analysis

    Mar 18, 2022, 01:00 by User Not Found
    Clinical Research News | Following a standard protocol when collecting biospecimens and conducting a quality review to confirm that you are working on appropriate samples are critically important processes for downstream analysis in medical research. If biospecimens are not collected and processed in the same way, subject to the same quality controls, diagnosis verification, and clinical data collection, researchers will not be able to determine whether data outliers are due to disease progression or process inconsistencies.
    Full story
  • Swiss CDMO expands capsule filling capabilities

    Mar 17, 2022, 12:26 by
    Full story
  • Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

    Mar 17, 2022, 12:26 by
    Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health
    Full story
  • Society of Toxicology Announced ScitoVation’s Senior Research Fellow, Jeffrey W. Fisher, PhD, Awarded 2022 SOT Arnold J. Lehman

    Mar 17, 2022, 12:26 by
    ScitoVation has announced that Jeffrey W. Fisher, PhD has been awarded the 2022 Society of Toxicology (SOT) Arnold J. Lehman Award.
    Full story
  • Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal

    Mar 17, 2022, 12:26 by
    Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal March 15, 2022 - North Carolina-based Triangle Business Journal recently unveiled the winners of its 2022 class of Health Care Leadership Awards, naming Rho as one of this year’s honorees. The global, full-service contract research organization (CRO) was chosen from a pool of Triangle-area nominees that work in a number of health care settings, including major hospital systems, small physician groups, life sciences firms and nonprofit health charities. "The honorees of this year’s Health Care Leadership Awards are making a significant impact on the quality of health care in the Triangle region," said Jason Christie, market president and publisher of TBJ. "This year’s honorees really are heroes in our community. Triangle Business Journal is pleased to honor them.”
    Full story
  • Curebase Rapidly Reaches Growth Milestone

    Mar 17, 2022, 12:26 by
    Decentralized Clinical Trial Platform Provider Welcomes 100th Teammate
    Full story
  • Tesis Biosciences Partners with Frontier Management to Provide Exclusive Pharmacogenetic Testing for Residents of Frontier’s Senior Living Facilities

    Mar 17, 2022, 12:25 by
    Tesis Biosciences Partners with Frontier Management to Provide Exclusive Pharmacogenetic Testing for Residents of Frontier’s Senior Living Facilities
    Full story
  • Enveda Biosciences Adds Drug Development Leaders to Scale Efforts and Accelerate Progress

    Mar 17, 2022, 12:25 by
    Full story
  • Merck Employs Virtual Reality To Combat Burden Of Long Study Visits

    Mar 16, 2022, 01:00 by User Not Found
    Clinical Research News | As Merck recently learned, relationships with scientific leaders and outside experts can be critical to enhancing the pediatric patient experience. That was one of the take-home messages from a case study on how the company executed on a virtual reality innovation that took first place honors during Participant Engagement Award ceremonies at the recent Summit for Clinical Ops Executives (SCOPE).
    Full story
  • New Pan-Cancer Prognostic Score Outperforms Existing Tools

    Mar 15, 2022, 15:40 by User Not Found
    Clinical Research News | Roche has developed a pan-cancer prognostic scoring system useful for predicting patient survival in clinical trials and monitoring treatment progress over time. The score comprises 27 routinely collected clinical parameters and outperforms all other existing scores in every study phase, according to Anna Bauer-Mehren, data science lead for Roche Pharmaceutical Research and Early Development in Germany.
    Full story
  • Calyx EDC Selected for RWE Data Collection in Lengthy, Late Phase Trial

    Mar 11, 2022, 14:05 by
    Leading pharmaceutical company trusts Calyx to meet accelerated timelines and support multi-year trials
    Full story
  • VitaDAO and Molecule AG partner with Apollo Health Ventures to build the longevity biotech & Web3 ecosystem

    Mar 11, 2022, 14:05 by
    Molecule has announced a tripartite partnership with Apollo Health Ventures and VitaDAO.
    Full story
  • MicrobioSeq Releases PCR-based Microbial Antibiotic Resistance Gene Analysis Service

    Mar 11, 2022, 14:05 by
    MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics MicrobioSeq is committed to delivering comprehensive microbial solutions to human health, agriculture, the environment, and industry by characterizing microbiomes and leveraging microorganisms. The company has recently announced the launch of PCR-based microbial antibiotic resistance gene analysis service to help researchers develop new antimicrobial medicines to address the worldwide threat of antibiotic resistance.
    Full story
  • CD Genomics: Bioinformatics-Analysis Division Provides Genotyping Analysis Service for Studying Genetic Variations

    Mar 11, 2022, 14:05 by
    Full story
  • CD ComputaBio Launches Homology Modeling Service for Drug Screening and Discovery

    Mar 11, 2022, 14:05 by
    As a reliable computational biology service provider based in New York, CD ComputaBio has recently launched homology modeling service to help researchers deeply understand the structure-activity relationship of the target protein, and provide strong support for structure-based rational drug design, protein function research, and protein engineering research. Relying on its professional team and advanced technology, as well as high-quality products and services, CD ComputaBio has gained a solid reputation.
    Full story
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126 (current)
  • 127
  • 128
  • 129
  • 130
  • »